Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract
- PMID: 11786907
- DOI: 10.1038/nm0102-54
Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract
Abstract
Respiratory syncytial virus (RSV) is a major cause of morbidity from respiratory infection in infants, young children and the elderly. No effective vaccine against RSV is currently available and studies of the natural history of RSV infection suggest repeated infections with antigenically related virus strains are common throughout an individual's lifetime. We have studied the CD8+ T-cell response during experimental murine RSV infection and found that RSV inhibits the expression of effector activity by activated RSV-specific CD8+ T cells infiltrating the lung parenchyma and the development of pulmonary CD8+ T-cell memory by interfering with TCR-mediated signaling. These data suggest a possible mechanism to explain the limited duration of protective immunity in RSV infection.
Similar articles
-
Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.Eur J Immunol. 2002 Aug;32(8):2117-23. doi: 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C. Eur J Immunol. 2002. PMID: 12209623
-
Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.Eur J Immunol. 2002 Sep;32(9):2562-9. doi: 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4. Eur J Immunol. 2002. PMID: 12207340
-
Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.J Immunol. 2010 Dec 15;185(12):7633-45. doi: 10.4049/jimmunol.0903452. Epub 2010 Nov 17. J Immunol. 2010. PMID: 21084664
-
Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system.Proc Am Thorac Soc. 2005;2(2):141-6. doi: 10.1513/pats.200503-022AW. Proc Am Thorac Soc. 2005. PMID: 16113482 Review.
-
CD8+ T cell immunity against human respiratory syncytial virus.Vaccine. 2014 Oct 21;32(46):6130-7. doi: 10.1016/j.vaccine.2014.08.063. Epub 2014 Sep 16. Vaccine. 2014. PMID: 25223272 Review.
Cited by
-
Genetic absence of PD-L1 does not restore CD8+ T cell function during respiratory virus infection and delays virus clearance.J Virol. 2024 Oct 22;98(10):e0079724. doi: 10.1128/jvi.00797-24. Epub 2024 Sep 23. J Virol. 2024. PMID: 39311697
-
Nasopharyngeal and Peripheral Blood Type II Interferon Signature Evaluation in Infants during Respiratory Syncytial Virus Infection.Medicina (Kaunas). 2024 Feb 2;60(2):259. doi: 10.3390/medicina60020259. Medicina (Kaunas). 2024. PMID: 38399546 Free PMC article.
-
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.J Virol. 2005 Aug;79(15):9515-26. doi: 10.1128/JVI.79.15.9515-9526.2005. J Virol. 2005. PMID: 16014914 Free PMC article.
-
Incomplete Memories: The Natural Suppression of Tissue-Resident Memory CD8 T Cells in the Lung.Front Immunol. 2018 Jan 22;9:17. doi: 10.3389/fimmu.2018.00017. eCollection 2018. Front Immunol. 2018. PMID: 29403499 Free PMC article.
-
The increased type-1 and type-2 chemokine levels in children with acute RSV infection alter the development of adaptive immune responses.Biomed Res Int. 2014;2014:750521. doi: 10.1155/2014/750521. Epub 2014 Jun 11. Biomed Res Int. 2014. PMID: 25013801 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials